Related Experiment Videos
Inherited defects of coagulation factor V: the hemorrhagic side
R Asselta1, M L Tenchini, S Duga
1Department of Biology and Genetics for Medical Sciences, University of Milan, Milan, Italy.
Journal of Thrombosis and Haemostasis : JTH
|January 18, 2006
Summary
Coagulation factor V (FV) balances blood clot formation, acting as both a procoagulant and anticoagulant. Genetic defects in FV can lead to bleeding or clotting disorders, with type I deficiency showing significant genetic diversity.
Area of Science:
- Hematology
- Molecular Biology
- Genetics
Background:
- Coagulation factor V (FV) is crucial for thrombin generation via the prothrombinase complex.
- FV also regulates anticoagulation by downregulating factor VIII activity.
- FV's dual role allows it to balance opposing forces in hemostasis.
Purpose of the Study:
- To review the structural, procoagulant, and anticoagulant properties of FV.
- To focus on bleeding disorders linked to altered FV levels.
- To examine the mutational spectrum of type I FV deficiency.
Main Methods:
- Literature review of FV structure and function.
- Analysis of genetic defects and associated phenotypes.
- Detailed examination of type I FV deficiency mutations.
Main Results:
- FV exhibits a dual role, acting as both a procoagulant and anticoagulant.
- Genetic FV defects can manifest as hemorrhagic or thrombotic phenotypes.
- Type I FV deficiency presents significant genetic heterogeneity and uneven mutation distribution.
Conclusions:
- FV is a critical regulator of hemostasis with a dual function.
- Altered FV levels and genetic defects contribute to bleeding and thrombotic disorders.
- Understanding FV's genetic heterogeneity is key for diagnosing and managing FV deficiencies.